Company profile
Home | Gliagenesis Limited
Gliagenesis Limited is a UK company with status active founded in 2017 based in South East England.
Updated 06 Jun 2026 16:52
Financial period: 1 Sep 2023 to 31 Aug 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
CS01 | Transaction MzQzMjYxODE3NWFkaXF6a2N4
Published 19 Aug 2024 11:56
Company registered at Companies House
Normal brain ageing is also associated with a significant loss of glial cells and white matter within the brain after people reach approximately 50 years of age. Glia are essential for neuronal function, survival and integrity. Alzheimer's, Parkinson's and Motor Neuron Diseases (ALS) as well as Multiple Sclerosis are all neurodegenerative diseases in which glial cell loss is now known to play a fundamental role in their neuropathology. Our aim is to provide greater insight into how glial cells aid and support neurons and find new therapeutics that can selectively promote survival of existing glial cells and prompt their regeneration.
GliaGenesis Limited is a UK-based biotech company focused on developing therapies for neurodegenerative diseases utilizing astrocytes.
None to date
